Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr1259 Inhibitors

Olr1259 inhibitors are a class of chemical compounds designed to specifically target the Olr1259 receptor, an olfactory receptor that belongs to the G protein-coupled receptor (GPCR) superfamily. These receptors are essential components of the olfactory system, which is responsible for detecting and processing odorant molecules to create the perception of smell. Olr1259 inhibitors function by binding to the receptor's active site or other key regions, thereby blocking the receptor's ability to interact with its natural ligands. This binding action prevents the receptor from undergoing the conformational changes necessary to trigger the intracellular signaling pathways typically initiated by odorant binding. As a result, these inhibitors effectively interfere with the receptor's role in olfactory signal transduction, reducing or halting its ability to transmit sensory information. The design and development of Olr1259 inhibitors often involve detailed studies of the receptor's structure, using techniques such as X-ray crystallography, molecular modeling, and cryo-electron microscopy. These structural insights are crucial for creating inhibitors that are highly specific to the Olr1259 receptor, ensuring they modulate its activity with precision.

Chemically, Olr1259 inhibitors exhibit a broad range of molecular structures, reflecting the different synthetic strategies employed in their development. These compounds can vary from small, lipophilic molecules that easily penetrate cell membranes to more complex, larger molecules that may require specialized synthesis techniques to achieve the desired binding affinity and specificity. The synthesis of Olr1259 inhibitors typically involves multiple steps of organic chemistry, including the construction of molecular scaffolds and the incorporation of functional groups that enhance binding interactions with the receptor. After synthesis, these compounds undergo extensive characterization using analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and high-performance liquid chromatography (HPLC). These methods are used to verify the structural integrity, purity, and inhibitory activity of the compounds. The study of Olr1259 inhibitors provides valuable insights into the molecular mechanisms underlying olfaction, particularly in understanding how specific olfactory receptors function and how their activity can be modulated by small molecules. Additionally, this research contributes to the broader field of GPCR biology, offering important knowledge about how these complex receptors can be selectively targeted and regulated. This understanding is essential for advancing our comprehension of sensory perception, particularly in the context of smell, and the intricate biochemical processes involved in GPCR-mediated signal transduction.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Afatinib-d4

850140-72-6 (unlabeled)sc-481821
10 mg
$4665.00
(0)

EGFR, HER2, and HER4 inhibitor, potentially influences signal transduction pathways intersecting with Olr1259.

XL-184 free base

849217-68-1sc-364657
sc-364657A
5 mg
10 mg
$92.00
$204.00
1
(1)

Targets MET, VEGFR, and AXL, possibly affecting pathways related to cell growth, potentially intersecting with Olr1259.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$112.00
$163.00
$928.00
19
(1)

MEK inhibitor, potentially modifies MAPK/ERK pathway, which could intersect with Olr1259's signaling role.

Regorafenib

755037-03-7sc-477163
sc-477163A
25 mg
50 mg
$320.00
$430.00
3
(0)

Targets multiple kinases, potentially influences cell signaling pathways where Olr1259 could be implicated.

Vandetanib

443913-73-3sc-220364
sc-220364A
5 mg
50 mg
$167.00
$1353.00
(1)

Targets RET, VEGFR, and EGFR, potentially affects pathways related to angiogenesis and cell growth linked to Olr1259.

AP 24534

943319-70-8sc-362710
sc-362710A
10 mg
50 mg
$172.00
$964.00
2
(1)

BCR-ABL, FLT3, FGFR, and SRC inhibitor, might modify signaling pathways, indirectly affecting Olr1259's function.

Lenvatinib

417716-92-8sc-488530
sc-488530A
sc-488530B
5 mg
25 mg
100 mg
$178.00
$648.00
$1657.00
3
(0)

Inhibits multiple receptor tyrosine kinases, could impact pathways potentially connected to Olr1259.

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

CDK4/6 inhibitor, potentially alters cell cycle pathways, intersecting with Olr1259's activity.

Ribociclib

1211441-98-3sc-507367
10 mg
$450.00
(0)

Another CDK4/6 inhibitor, potentially influences cell proliferation and survival pathways linked to Olr1259.

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

EGFR inhibitor, might modify signaling pathways, potentially affecting Olr1259's function.